CITIUS ONCOLOGY, INC. - CTOR

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2026 · Q2 2026
Value (USD)
Total reported value ($000)
$9.225M
QoQ value delta ($000)
+$39K (+0.42%)
Implied price effect (QoQ)
+0.42%
Shares
Total shares
14,145,277
QoQ shares delta
0 (0.0%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (CTOR)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2026)

Top 25 only Full list
Partial Q3 2026 data: 1 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
ARMISTICE CAPITAL, LLC 5,659 8,705,589 0.07%
BANK OF AMERICA CORP /DE/ 2,492 3,835,160 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 355 546,325 0.0%
UBS Group AG 217 334,619 0.0%
GEODE CAPITAL MANAGEMENT, LLC 159 245,407 0.0%
IFP Advisors, Inc 108 107,424 0.0%
VANGUARD FIDUCIARY TRUST CO 79 121,910 0.0%
CITADEL ADVISORS LLC 58 90,586 0.0%
NORTHERN TRUST CORP 29 45,746 0.0%
STATE STREET CORP 27 42,900 0.0%
Virtu Financial LLC 14 21,877 0.0%
XTX Topco Ltd 13 20,638 0.0%
Tower Research Capital LLC (TRC) 8 13,816 0.0%
Arkadios Wealth Advisors 7 11,666 0.0%
WELLS FARGO & COMPANY/MN 0 500 0.0%
BARCLAYS PLC 0 90 0.0%
MORGAN STANLEY 0 23 0.0%
OSAIC HOLDINGS, INC. 0 1,000 0.0%
Caitong International Asset Management Co., Ltd 0 1 0.0%